Sector revisions Amgen Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 18:13:15 11/02/2026 GMT			5-day change	1st Jan Change
363.66 ^USD	-0.27%		-0.24%	+11.61%

02-10	Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating	MT
02-10	Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	AMGEN INC.							27
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							20
	NOVARTIS AG							21
	ASTRAZENECA PLC							21
	MERCK & CO., INC.							26
	NOVO NORDISK A/S							22
	GILEAD SCIENCES, INC.							25
	PFIZER INC.							23
	BRISTOL-MYERS SQUIBB COMPANY							23
	VERTEX PHARMACEUTICALS INCORPORATED							25
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	BAYER AG							20
	Average							22
	Weighted average by Cap.							24